These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 10219447)

  • 1. Ovarian cancer: should we be managing patients with good and bad prognostic factors in the same manner?
    Eisenhauer EA; Gore M; Neijt JP
    Ann Oncol; 1999; 10 Suppl 1():9-15. PubMed ID: 10219447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of resistance to systemic therapy in patients with breast cancer.
    Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
    Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of apoptosis-related proteins is an independent determinant of patient prognosis in advanced ovarian cancer.
    Baekelandt M; Holm R; Nesland JM; Tropé CG; Kristensen GB
    J Clin Oncol; 2000 Nov; 18(22):3775-81. PubMed ID: 11078490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prognostic and predictive factors in epithelial ovarian cancer].
    Boudou-Rouquette P; Pautier P; Morice P; Lhommé C
    Bull Cancer; 2009 Apr; 96(4):425-37. PubMed ID: 19357017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic.
    Wahner Hendrickson AE; Hawthorne KM; Goode EL; Kalli KR; Goergen KM; Bakkum-Gamez JN; Cliby WA; Keeney GL; Visscher DW; Tarabishy Y; Oberg AL; Hartmann LC; Maurer MJ
    Gynecol Oncol; 2015 Apr; 137(1):77-85. PubMed ID: 25620544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tissue array analysis of expression microarray candidates identifies markers associated with tumor grade and outcome in serous epithelial ovarian cancer.
    Ouellet V; Guyot MC; Le Page C; Filali-Mouhim A; Lussier C; Tonin PN; Provencher DM; Mes-Masson AM
    Int J Cancer; 2006 Aug; 119(3):599-607. PubMed ID: 16572426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic factors in stage I ovarian carcinoma.
    Vergote I
    Verh K Acad Geneeskd Belg; 2001; 63(3):257-71; discussion 272-6. PubMed ID: 11499346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment and prognostic analysis of ovarian cancer patients with isolated region of lymph node recurrence].
    Tu H; Huang H; Huang QD; Li Z; Feng YL; Liu JH
    Zhonghua Fu Chan Ke Za Zhi; 2012 Dec; 47(12):928-33. PubMed ID: 23324194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer.
    Jatoi A; Vierkant RA; Hawthorne KM; Block MS; Ramus SJ; Larson NB; Fridley BL; Goode EL
    Oncology; 2016; 90(2):59-68. PubMed ID: 26780780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new prognostic model comprising p53, EGFR, and tumor grade in early stage epithelial ovarian carcinoma and avoiding the problem of inaccurate surgical staging.
    Skírnisdóttir I; Seidal T; Sorbe B
    Int J Gynecol Cancer; 2004; 14(2):259-70. PubMed ID: 15086725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of ITM2A, a novel tumor suppressor of ovarian cancer through G2/M cell cycle arrest, is a poor prognostic factor of epithelial ovarian cancer.
    Nguyen TM; Shin IW; Lee TJ; Park J; Kim JH; Park MS; Lee EJ
    Gynecol Oncol; 2016 Mar; 140(3):545-53. PubMed ID: 26691219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evidence-based radiotherapy in the treatment of early-stage invasive breast cancer: traditional clinical features and biomarkers].
    Fodor J
    Magy Onkol; 2009 Mar; 53(1):7-14. PubMed ID: 19318321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.
    Pinto MP; Balmaceda C; Bravo ML; Kato S; Villarroel A; Owen GI; Roa JC; Cuello MA; Ibañez C
    Gynecol Oncol; 2018 Oct; 151(1):10-17. PubMed ID: 30078505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and predictive values of Nrf2, Keap1, p16 and E-cadherin expression in ovarian epithelial carcinoma.
    Liew PL; Hsu CS; Liu WM; Lee YC; Lee YC; Chen CL
    Int J Clin Exp Pathol; 2015; 8(5):5642-9. PubMed ID: 26191276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic factors in ovarian cancer.
    Tropé C
    Cancer Treat Res; 1998; 95():287-352. PubMed ID: 9619290
    [No Abstract]   [Full Text] [Related]  

  • 16. Early detection and prognosis of ovarian cancer using serum YKL-40.
    Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
    J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diagnosis and follow-up observation of granulosa cell tumor of the ovary are becoming more precise].
    Färkkilä A; Unkila-Kallio L
    Duodecim; 2016; 132(11):1033-9. PubMed ID: 27400589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer].
    Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019
    [No Abstract]   [Full Text] [Related]  

  • 19. [Histologic classification and morphologic prognostic factors in malignant ovarian tumors].
    Horn LC; Fricke K; Krugmann J
    Zentralbl Gynakol; 1995; 117(7):335-45. PubMed ID: 7668062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
    Marx D; Binder C; Meden H; Lenthe T; Ziemek T; Hiddemann T; Kuhn W; Schauer A
    Anticancer Res; 1997; 17(3C):2233-40. PubMed ID: 9216694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.